China Sinovac says it reached two billion doses annual capacity for Covid-19 vaccine
A Sinovac spokesman said the third facility, in Beijing, had started cultivating cells where the coronavirus would be grown, a procedure that could take a relatively long time
A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
China's Sinovac Biotech said on Friday its third production plant for its Covid-19 vaccine was ready and had started manufacturing procedures for bulk vaccine ingredient, doubling its annual capacity to 2 billion doses.
A Sinovac spokesman said the third facility, in Beijing, had started cultivating cells where the coronavirus would be grown, a procedure that could take a relatively long time.
Sinovac did not say when it will actually produce 2 billion doses of the vaccine.
Keep updated, follow The Business Standard's Google news channel
More than 200 million doses of Sinovac's vaccine named CoronaVac have been delivered globally, up from 160 million doses announced on March 22.
The firm said it estimated over 100 million doses have been administered worldwide.
